Process View
The chemical reactions and pathways resulting in the breakdown of menaquinones, any of the quinone-derived compounds synthesized by intestinal bacteria. Structurally, menaquinones consist of a methylated naphthoquinone ring structure and side chains composed of a variable number of unsaturated isoprenoid residues. Menaquinones have vitamin K activity and are known as vitamin K2.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "menaquinone catabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.996 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.855 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.820 | Human | |
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.777 | Human | |
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.759 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.512 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.420 | ||
| C8A | complement component 8, alpha polypeptide | 0.343 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.285 | ||
| KNG1 | kininogen 1 | 0.233 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.149 | ||
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.147 | ||
| PLG | plasminogen | 0.120 | ||
| DAO | D-amino-acid oxidase | 0.102 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.097 | ||
| SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.096 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.094 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.087 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.080 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.079 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.077 | ||
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.076 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.064 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.063 | ||
| CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.061 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.059 | Human | |
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.059 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.058 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.058 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.057 | ||
| SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.055 | ||
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.054 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.052 | ||
| CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.045 | ||
| HRG | histidine-rich glycoprotein | 0.045 | ||
| SULT2B1 | sulfotransferase family, cytosolic, 2B, member 1 | 0.041 | ||
| SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 0.039 | ||
| DIO1 | deiodinase, iodothyronine, type I | 0.038 | ||
| ARG1 | arginase, liver | 0.036 | ||
| OTC | ornithine carbamoyltransferase | 0.036 | ||
| CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 | 0.036 | Human | |
| C8B | complement component 8, beta polypeptide | 0.035 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.035 | ||
| GLYAT | glycine-N-acyltransferase | 0.034 | ||
| F9 | coagulation factor IX | 0.034 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.033 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.031 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.030 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.030 | ||
| FETUB | fetuin B | 0.029 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.028 | ||
| ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.028 | ||
| SEC14L2 | SEC14-like 2 (S. cerevisiae) | 0.028 | ||
| PAH | phenylalanine hydroxylase | 0.028 | ||
| SCGB2A1 | secretoglobin, family 2A, member 1 | 0.027 | ||
| PIP | prolactin-induced protein | 0.027 | ||
| HAL | histidine ammonia-lyase | 0.026 | ||
| GSTA3 | glutathione S-transferase alpha 3 | 0.025 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.024 | ||
| UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 | 0.023 | ||
| SCNN1A | sodium channel, nonvoltage-gated 1 alpha | 0.023 | ||
| HGD | homogentisate 1,2-dioxygenase | 0.023 | ||
| CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 0.022 | Human | |
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.022 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.022 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.022 | ||
| F13B | coagulation factor XIII, B polypeptide | 0.021 | ||
| SLC28A1 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 | 0.021 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.021 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.021 | ||
| ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 0.021 | ||
| APOF | apolipoprotein F | 0.021 | ||
| KRT13 | keratin 13 | 0.020 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.020 | ||
| EPHX2 | epoxide hydrolase 2, cytoplasmic | 0.020 | ||
| DEFB1 | defensin, beta 1 | 0.019 | ||
| ORM1 | orosomucoid 1 | 0.019 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.019 | ||
| C9 | complement component 9 | 0.019 | ||
| NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 0.018 | ||
| APOC3 | apolipoprotein C-III | 0.018 | ||
| NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | 0.018 | ||
| SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 | 0.018 | ||
| GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.018 | ||
| CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | 0.018 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.017 | ||
| C6 | complement component 6 | 0.017 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.017 | ||
| LPA | lipoprotein, Lp(a) | 0.017 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.017 | ||
| ADRA1A | adrenergic, alpha-1A-, receptor | 0.016 | ||
| DPYS | dihydropyrimidinase | 0.016 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.015 | ||
| FABP2 | fatty acid binding protein 2, intestinal | 0.015 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.015 | ||
| PRLR | prolactin receptor | 0.015 | ||
| C8G | complement component 8, gamma polypeptide | 0.015 | ||
| CFHR4 | complement factor H-related 4 | 0.014 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.014 | ||
| BBOX1 | butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | 0.014 | ||
| CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.014 | ||
| HPX | hemopexin | 0.014 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.014 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.014 | ||
| GPX2 | glutathione peroxidase 2 (gastrointestinal) | 0.013 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.013 | ||
| SLC13A2 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | 0.013 | ||
| ALDH3A1 | aldehyde dehydrogenase 3 family, member A1 | 0.012 | ||
| FMO4 | flavin containing monooxygenase 4 | 0.012 | ||
| TREH | trehalase (brush-border membrane glycoprotein) | 0.012 | ||
| C4BPB | complement component 4 binding protein, beta | 0.012 | ||
| IGFALS | insulin-like growth factor binding protein, acid labile subunit | 0.012 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.012 | ||
| AQP7 | aquaporin 7 | 0.012 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.012 | ||
| KRT4 | keratin 4 | 0.012 | ||
| CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 0.012 | ||
| ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.011 | ||
| CRP | C-reactive protein, pentraxin-related | 0.011 | ||
| PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | 0.011 | ||
| PRODH | proline dehydrogenase (oxidase) 1 | 0.011 | ||
| CYP4A22 | cytochrome P450, family 4, subfamily A, polypeptide 22 | 0.011 | Human | |
| CNGA1 | cyclic nucleotide gated channel alpha 1 | 0.011 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.011 | ||
| PIPOX | pipecolic acid oxidase | 0.011 | ||
| CA5A | carbonic anhydrase VA, mitochondrial | 0.011 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.011 | ||
| VTCN1 | V-set domain containing T cell activation inhibitor 1 | 0.011 | ||
| S100A14 | S100 calcium binding protein A14 | 0.011 | ||
| CRISP3 | cysteine-rich secretory protein 3 | 0.011 | ||
| IL1RL2 | interleukin 1 receptor-like 2 | 0.010 | ||
| KHK | ketohexokinase (fructokinase) | 0.010 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.010 | ||
| GSTT1 | glutathione S-transferase theta 1 | 0.010 | ||
| CCL16 | chemokine (C-C motif) ligand 16 | 0.010 | ||
| B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | 0.010 | ||
| UPB1 | ureidopropionase, beta | 0.010 | ||
| HSD11B2 | hydroxysteroid (11-beta) dehydrogenase 2 | 0.010 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.010 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.010 | ||
| CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 | 0.010 |